Australia markets closed

Centogene N.V. (CNTG)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.7500+0.0351 (+4.91%)
At close: 03:55PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 21.53M
Enterprise value 26.51M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.09
Price/book (mrq)0.63
Enterprise value/revenue 0.14
Enterprise value/EBITDA -1.29

Trading information

Stock price history

Beta (5Y monthly) -0.99
52-week change 3-87.32%
S&P500 52-week change 3-15.73%
52-week high 36.1100
52-week low 30.6800
50-day moving average 30.9265
200-day moving average 32.2075

Share statistics

Avg vol (3-month) 321.23k
Avg vol (10-day) 346.42k
Shares outstanding 527.08M
Implied shares outstanding 6N/A
Float 87.8M
% held by insiders 120.83%
% held by institutions 166.75%
Shares short (14 Nov 2022) 432.53k
Short ratio (14 Nov 2022) 41.3
Short % of float (14 Nov 2022) 40.25%
Short % of shares outstanding (14 Nov 2022) 40.12%
Shares short (prior month 13 Oct 2022) 425.77k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -25.46%
Operating margin (ttm)-18.51%

Management effectiveness

Return on assets (ttm)-17.37%
Return on equity (ttm)-91.40%

Income statement

Revenue (ttm)190.27M
Revenue per share (ttm)8.39
Quarterly revenue growth (yoy)3.50%
Gross profit (ttm)35.9M
EBITDA -21.55M
Net income avi to common (ttm)-43.81M
Diluted EPS (ttm)-2.1970
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)42.67M
Total cash per share (mrq)1.58
Total debt (mrq)42.96M
Total debt/equity (mrq)130.94
Current ratio (mrq)2.48
Book value per share (mrq)1.20

Cash flow statement

Operating cash flow (ttm)-31.88M
Levered free cash flow (ttm)-8.42M